NASDAQIndustrialsManufacturing - Metal FabricationSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for TPCS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Execute backlog over next 1-3 years | The company is executing backlog over the next 1-3 years. | Improving | Backlog execution falters causing revenue decline below $34M | Revenue: $9.096M FY2027-Q1; GAAP. Published target: sustain backlog delivery progress over next 3 years. Target period is not explicitly aligned with this observation. Aug 13, 20269,096,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk turnaround and execution story, not a durable compounder today. The thesis is on watch: management is making progress on margins and EBITDA, while recent financial performance remains weak and the business is still loss-making.
The evidence describes TPCS as cheap versus peers, with a near-zero expectations gap, so the valuation does not signal a large cushion against weak results. Priced-in fragility is low, but valuation-model confidence is medium and the company remains loss-making.
Over the next one to three years, management aims to deliver its funded backlog and improve gross margins; recent gross-margin and gross-profit results show progress. EBITDA also improved in the latest quarter, and management maintains its fiscal 2027 growth goal, but recent earnings misses make another near-term miss a meaningful risk.
The multi-year thesis hinges on turning the backlog into revenue while sustaining margin gains and progress toward management's EBITDA goal. A guidance cut or weaker results from industrial bellwethers would add pressure, while continued strong results and higher guidance from those peers would support the sector backdrop.
TPCS shows better momentum and some execution progress, but losses, repeated earnings misses, and weak performance versus its industry keep the 1-to-3-year thesis uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 1 of 1 supplied quarters. Management reported: ““We expect to deliver this backlog over the next one to three fiscal years with expectations for gross margin improvement throughout the period.”” ““We expect to deliver this backlog over the next one to three fiscal years with expectations for gross margin improvement throughout the period.””
Achieve EBITDA growth to $3.0M-$4.0M in fiscal 2027 | A primary condition in TechPrecision Corp's published investment case. The stated target is 3.5 USD_MILLIONS. | Intact | EBITDA falls below $3.0M in fiscal 2027 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve gross margin to 27% by 2026-Q2 | Gross margin improvement to 27% is a key focus. | Broken | Gross margin falls below 14% by 2026-Q2 | Gross margin: 15.39% FY2027-Q1; GAAP. Published target: 27 PERCENT. Target percentage unit is not explicit. Aug 13, 202615.391381 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: ““For the fiscal year 2026, consolidated gross profit increased by 15% and our consolidated gross margin expanded by 300 basis points as the Company implemented a strategic project mix change at Stadco, resulting in reduced revenue with higher margin drop-through.,” stated Alexander Shen, TechPrecision’s Chief Executive Officer.” “Consolidated gross profit was $1.4 million or 36% higher than the same period a year ago.” Delivery assessment Nov 4, 2026 |
Grow consolidated revenue to ~$36M in fiscal 2027 | TechPrecision aims to grow revenue to about $36M in fiscal 2027. | Intact | Revenue falls below $34M in fiscal 2027 | Revenue: $9.096M FY2027-Q1; GAAP. Published target: ~36.0 USD_MILLIONS. Target period is not explicitly aligned with this observation. Aug 13, 20269,096,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: ““We expect to deliver this backlog over the next one to three fiscal years with expectations for gross margin improvement throughout the period.”” ““We expect to deliver this backlog over the next one to three fiscal years with expectations for gross margin improvement throughout the period.”” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.